Here's why Abbott India stock price surged 5% on August 8; details here

Q: How long will it take to read this news story?

The story "Here&#039;s why Abbott India stock price surged 5% on August 8; details here" has 483 words across 21 sentences, which will take approximately 3 - 5 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Here&#039;s why Abbott India stock price surged 5% on August 8; details here" was covered 5 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 294 news stories per day. It's most recent story was published 2 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #21979246</li><li>URL: https://beamstart.com/news/heres-why-abbott-india-stock-17231011113589</li></ul>

Business Standard Logo Business Standard 5h ago

Here's why Abbott India stock price surged 5% on August 8; details here - Business Standard

Quick Summary:

The uptick in the pharma company's stock price came after it posted a healthy set of numbers in the June quarter of financial year 2025 (Q1FY25).

The company offers a diverse portfolio of over 125 products across various therapeutic areas, including women's health, gastroenterology, central nervous system (CNS) disorders, metabolics, pain management, insomnia, nutritional supplements, vitamins, vaccines, and consumer health.

With a presence in over 160 countries and a legacy spanning more than 130 years, Abbott India is a major player in the pharmaceutical sector.